Overview

A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies

Status:
Completed
Trial end date:
2006-11-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the side effects and antitumor response of patients with lymphoid malignancies to Deoxycoformycin (DCF)/Pentostatin.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
Pentostatin